An experimental drug being developed by South San Francisco-based biotech Cytokinetics improved cardiac function in a mid-stage clinical trial of several dozen patients with a type of heart disease, the company said Monday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,